Eprodisate

Eprodisate

SCHEMBL218553

O=S(=O)([O-])CCCS(=O)(=O)[O-].[Ag+2]

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.58
SMN1; SMN2 Q16637 2/20 0.58
GMNN O75496 1/20 0.58
LMNA P02545 1/20 0.58
TP53 P04637 1/20 0.58
TSHR P16473 1/20 0.58
MAPK1 P28482 1/20 0.58
THPO P40225 1/20 0.58
HBB P68871 1/20 0.58
PMP22 Q01453 1/20 0.58
BBOX1 O75936 3/20 0.52
KDM4E B2RXH2 2/20 0.47
MAPT P10636 1/20 0.47
ALOX15 P16050 1/20 0.47
ENPEP Q07075 2/20 0.42
PABPC1 P11940 1/20 0.33
EIF4H Q15056 1/20 0.33
CTDSP1 Q9GZU7 1/20 0.33
CYP3A4 P08684 1/20 0.31
CYP2C9 P11712 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Eprodisate SCHEMBL218551 0.92 ALDH1A1 (0.58) ALDH1A1SMN1; SMN2GMNNLMNATP53
Eprodisate SCHEMBL2522165 0.92 ALDH1A1 (0.58) ALDH1A1SMN1; SMN2GMNNLMNATP53
Eprodisate SCHEMBL4422542 0.92 ALDH1A1 (0.58) ALDH1A1SMN1; SMN2GMNNLMNATP53
Eprodisate SCHEMBL11909837 0.92 ALDH1A1 (0.58) ALDH1A1SMN1; SMN2GMNNLMNATP53
Eprodisate SCHEMBL12979823 0.92 ALDH1A1 (0.58) ALDH1A1SMN1; SMN2GMNNLMNATP53
Eprodisate SCHEMBL293813 0.92 ALDH1A1 (0.67) ALDH1A1SMN1; SMN2GMNNLMNATP53
Eprodisate SCHEMBL2288868 0.92 ALDH1A1 (0.58) ALDH1A1SMN1; SMN2GMNNLMNATP53
Eprodisate SCHEMBL2519328 0.92 ALDH1A1 (0.58) ALDH1A1SMN1; SMN2GMNNLMNATP53
SCHEMBL14974551 0.85 ALDH1A1 (0.58) ALDH1A1SMN1; SMN2GMNNLMNATP53
Potassium Ion SCHEMBL28472448 0.85 ALDH1A1 (0.58) ALDH1A1SMN1; SMN2GMNNLMNATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8088548-B2 Bottom antireflective coating compositions AZ ELECTRONIC MATERIALS USA CORP. (US) 2012-01-03 US disclosed
US-20090104559-A1 Bottom Antireflective Coating Compositions MERCK PATENT GMBH (DE) 2009-04-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090104559-A1 Bottom Antireflective Coating Compositions SDC2, S100A9, MYH9 ALDH1A1 3154/4885SMN1; SMN2 579/4885GMNN 571/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.